Blogs
KCAS Bio will be at the 18th EBF Open Symposium : “Tuning in to Tomorrow: Science in High Definition.” Connecting with the Bioanalytical Community Like every year, our team will be on site to reconnect with the with the bioanalytical community, exchange ideas, and discuss the latest developments in…
News
OLATHE, Kan.–(BUSINESS WIRE)–KCAS Bio, a leading contract research organization (CRO) specializing in comprehensive bioanalytical and biomarker services, is delighted to announce the appointment of Dr. Paul Kirchgraber and Mr. Kurt Doyle to its Board of Directors. Their addition marks a significant milestone in KCAS Bio’s continued growth and strategic evolution…
Podcasts
In this episode, hosts Dom and John welcome Jason Hannah, Director of Marketing at KCAS Bio, to discuss the company’s strategy for navigating the 2025 global conference season. With major events like AAPS PharmSci 360 in the U.S. and the European Bioanalysis Forum (EBF) in Barcelona on the horizon, Jason…
webinars
In drug development, there is a growing demand for ultrasensitive bioanalytical platforms and kits, especially in disciplines like neuroscience, where analytes are often present at very low concentrations in peripheral circulation. KCAS Bio addresses this demand by offering a spectrum of technologies, from dedicated platforms to ultra-sensitive kits on conventional…
Blogs
In the drug development landscape, biomarkers are important tools that are used as strategic drivers of decision-making. From target engagement to safety monitoring and patient stratification, biomarkers accelerate clinical development and increase the probability of success. But not all biomarkers are created equal, and their value depends heavily on…
Blogs
What Are Ligand Binding Assays (LBAs)? Ligand binding assays (LBAs) have been our core activity for decades. LBAs are commonly used to measure interactions between two proteins, a ligand and its receptor, a monoclonal antibody (mAb) and its target, or a biologic and Anti-Drug Antibodies (ADA). Applications of…
Podcasts
In episode 25 of “The Conversational Flow” podcast, guest David Leclerc, Director of the Cytometry and Antibody Technology (CAT) Facility at the University of Chicago, joins Brian and Adam to share his professional journey and insights into the evolving world of flow cytometry. Leclerc reflects on his early struggles during…
webinars
In the evolving landscape of drug development, biomarkers are increasingly vital in driving decisions across preclinical and clinical studies. From patient stratification and efficacy monitoring to safety assessments and pharmacodynamic evaluations, biomarkers are critical tools for reducing development timelines and increasing the likelihood of regulatory success. But with so many…
Blogs
As an emerging and growing application, spectral flow cytometry offers capabilities beyond what is possible with conventional flow. Its unique capabilities make it a powerful tool for scientists aiming to extract more information from each sample and push the boundaries of discovery. Join us in this post as we…
Blogs
In a bioanalytical CRO, method development is a critical step to ensure reliable and meaningful data that meets the client’s requirements. At our KCAS Bio – Lyon site, our method development team specializes in designing and optimizing ligand-binding assay (LBA) methods tailored to our clients’ specific objectives. While…
Posters & Papers
Discover in this poster presented by Shalini Gautam, PhD, at ICCS 2025, our work on the “Immunophenotypic Characterization of AML Blast Cells: A Pilot Study for Precision Therapeutic Targeting.“ Gautam_ICCS_2025Download If you have any questions about these services or others offered by KCAS…
October 9
- October 9
KCAS Bio is excited to sponsor the upcoming Pharmaceutical & BioScience Society (PBSS) workshop “Pharmacokinetics in Drug Discovery and Development: Fundamentals, Applications and Case Studies,” on October 9th from 8:45am – 5:30pm PST in Foster City, California at the Crowne Plaza Hotel. Advanced Pharmacokinetics for Small Molecules and Biologics…